| GTO ID | GTC2048 |
| Trial ID | NCT03814447 |
| Disease | Ovarian Cancer |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MESO CAR-T cells |
| Generation | 4th |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer |
| Year | 2019 |
| Country | China |
| Company sponsor | Shanghai 6th People's Hospital |
| Other ID(s) | MESO-CART |
| Cohort 1 | |||||||||||||
|
|||||||||||||